Close Menu

gastric cancer

The non-invasive, blood-based circulating tumor cell and circulating tumor DNA cancer tests will be made available to 19 million patients. 

In GIST tumors lacking genetic mutations, researchers uncover an epimutation affecting a gene promoter.

NEW YORK (GenomeWeb) – The non-profit No Stomach for Cancer said today it has awarded $100,000 to fund two research projects that will investigate the genetic basis of gastric cancer.

NEW YORK (GenomeWeb) – Two research teams reported on mutational patterns present in gastric cancer in Nature Genetics.

NEW YORK (GenomeWeb News) – Response Genetics today said it has signed agreements with four payors to provide access to the molecular diagnostic firm's tests.

RayBiotech is applying its protein array technology to internal protein biomarker discovery work.

NEW YORK (GenomeWeb News) – BGI and Portuguese startup Coimbra Genomics today announced a project to investigate the genetic basis of gastric cancer, the second most common cause of cancer after lung cancer.

NEW YORK (GenomeWeb News) – The National Institutes of Health said today that it has awarded $17 million to fund 24 new research projects seeking to understand how extracellular RNA is involved in communication between cells and how they may be used as biomarkers for diseases.

NEW YORK (GenomeWeb News) – Response Genetics today announced the execution of a provider contract with Blue Cross and Blue Shield of Illinois, providing the health plan's 7.4 million members coverage for the Los Angeles-based molecular diagnostics firm's tests.

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and Sengenics said today that they have formed a partnership to identify and validate auto-antibody signatures for the early detection of cancers.

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.